期刊文献+

非生物型人工肝与中药结肠透析优化治疗肝衰竭的临床研究 被引量:7

Clinical Research on Non-bioartificial Liver Combined with Traditional Chinese Medicine Colon Dialysis to Liver Failure
下载PDF
导出
摘要 目的观察非生物型人工肝与中药结肠透析优化治疗肝衰竭的治疗效果.方法随机选取昆明市第三人民医院103例肝衰竭应用非生物型人工肝血浆置换与中药结肠透析优化治疗的患者和100例仅行人工肝浆置换术治疗的患者,进行临床疗效的比较分析.结果血浆置换联合中药结肠透析治疗对肝功能、凝血酶原活动度、细胞因子指标的改善优于单纯的血浆置换(P<0.05);同时,在减少人工肝治疗频次、血浆用量比较优于单纯的血浆置换(P<0.05),从而降低患者住院总费用(P<0.05),减轻患者经济负担.结论非生物型人工肝血浆置换与中药结肠透析优化治疗肝衰竭优于单独的人工肝治疗。 Objective Observe the therapeutic effect of non-bioartificial liver combined with traditional Chinese medicine colon dialysis to liver failure. Methods 103 patients were randomly selected with non-bioartificial liver and traditional Chinese medicine colon dialysis therapy, 100 patients with non-bioartificial liver therapy, and the therapeutic effect of two groups was analyzed and compared by SPSS. Results Nnon-bioartificial liver plasma- pheresis combined with traditional Chinese medicine colon dialysis were better than simple plasmapheresis in treating live failure, including improving liver function, prothrombin activity , cytokines, reducing the therapeutic frequency and dosage of plasmapheresis, and reducing the health care cost. Conclusion Non-bioartificial liver combined with traditional Chinese medicine colon dialysis is better than primary artificial liver in liver failure treatment
出处 《昆明医科大学学报》 CAS 2015年第1期94-99,共6页 Journal of Kunming Medical University
基金 昆明市科技局基金资助项目(20120100BS020004)
关键词 非生物型人工肝 中药结肠透析 肝衰竭 Non-bioartificial liver Traditional Chinese medicine colon dialysis Liver failure
  • 相关文献

参考文献12

二级参考文献124

共引文献660

同被引文献108

  • 1Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association.肝衰竭诊疗指南[J].中华肝脏病杂志,2006,14(9):643-646. 被引量:829
  • 2李兰娟.肝衰竭诊疗指南[J].中华内科杂志,2006,45(12):1053-1056. 被引量:101
  • 3刘华新,刘慧玲.大黄在重症肝炎中的应用[J].湖北中医杂志,2007,29(1):40-41. 被引量:7
  • 4杨绍基.传染病学[M].北京:人民卫生出版社,2013.
  • 5Murakami K,Kawagishi N,Ishida K,et al. Fibrosing cholestatic hepatitis developing within one month after living donor liver transplantation for chronic hepatitis C-related cirrhosis:a case report. Transplant Proc,2014,46(3):995-998.
  • 6Vaid A,Chweich H,Balk EM,et al. Molecular adsorbent recir- culating system as artificial support therapy for liver failure:a meta-analysis. ASAIO J,2012,58(1):51-59.
  • 7Ince V,Aydin C,Otan E,et al. Comparison of plasmapheresis and molecular adsorbent recirculating system efficacy in graft failure after living donor liver transplantation. Transplant Proc, 2013,45(3):971-973.
  • 8Shinoda M,Tilles AW,Kobayashi N,et al. A bioartificial liver de- vice secreting interleukin-I receptor antagonist for the treatment of hepatic failure in rats. J Surg Res,2007,137(1):130-140.
  • 9Wiersema UF,Kim SW,Roxby D,et al. Therapeutic plasma ex- change does not reduce vasopressor requirement in severe acute liver failure:a retrospective case series. BMC Anesthesiol,2015, 15:30-33.
  • 10Oguchi Y,Tsurushima M,Tamura Y,et al. A ease of hepatitis B virus reactivation in a patient with prior resolved hepatitis B infection during bevacizumab plus FOLFIRI treatment. (;an To Kagaku Ryoho,2013,40( 11 ):1561-1563.

引证文献7

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部